Validation of measurement scales in ocular graft-versus-host disease

Ophthalmology

Volumn 119, Issue 3, 2012, Pages 487-493

  Inamoto, Yoshihiro ^a   Chai, Xiaoyu ^a   Kurland, Brenda F ^a   Cutler, Corey ^b   Flowers, Mary E D ^a   Palmer, Jeanne M ^c   Carpenter, Paul A ^a   Heffernan, Mary J ^a   Jacobsohn, David ^d   Jagasia, Madan H ^e   Pidala, Joseph ^f   Khera, Nandita ^a   Vogelsang, Georgia B ^g   Weisdorf, Daniel ^h   Martin, Paul J ^a   Pavletic, Steven Z ⁱ   Lee, Stephanie J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g JOHNS HOPKINS HOSPITAL   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; EYE DISEASE; FEMALE; HUMAN; LEE EYE SUBSCALE; MAJOR CLINICAL STUDY; MALE; OCULAR SURFACE DISEASE INDEX; PRIORITY JOURNAL; RATING SCALE; SCHIRMER TEST;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CONSENSUS DEVELOPMENT CONFERENCES, NIH AS TOPIC; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRY EYE SYNDROMES; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; SICKNESS IMPACT PROFILE; TRANSPLANTATION, HOMOLOGOUS; UNITED STATES; YOUNG ADULT;

EID: 84857915631     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.08.040     Document Type: Article

References (37)

1. F.R. Appelbaum, S.J. Forman, R.S. Negrin, K.G. Blume Thomas' hematopoietic cell transplantation 4th ed. 2009 Wiley-Blackwell Oxford, England 705 1199
2. G. Socie, J.V. Stone, J.R. Wingard Late Effects Working Committee of the International Bone Marrow Transplant Registry Long-term survival and late deaths after allogeneic bone marrow transplantation N Engl J Med 341 1999 14 21
3. S.J. Lee, D. Fairclough, S.K. Parsons Recovery after stem-cell transplantation for hematologic diseases J Clin Oncol 19 2001 242 252
4. T.L. Kiss, M. Abdolell, N. Jamal Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation J Clin Oncol 20 2002 2334 2343
5. C.J. Fraser, S. Bhatia, K. Ness Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study Blood 108 2006 2867 2873
6. J. Pidala, C. Anasetti, H. Jim Quality of life after allogeneic hematopoietic cell transplantation Blood 114 2009 7 19
7. J. Pidala, B. Kurland, X. Chai Patient reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium Blood 117 2011 4651 4657
8. S.J. Lee, G. Vogelsang, M.E. Flowers Chronic graft-versus-host disease Biol Blood Marrow Transplant 9 2003 215 233
9. B. Calissendorff, M. el Azazi, B. Lonnqvist Dry eye syndrome in long-term follow-up of bone marrow transplanted patients Bone Marrow Transplant 4 1989 675 678
10. A. Tichelli, T. Duell, M. Weiss European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors Bone Marrow Transplant 17 1996 1105 1111
11. M.E. Flowers, P.M. Parker, L.J. Johnston Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial Blood 100 2002 415 419
12. D. Couriel, P.A. Carpenter, C. Cutler Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V Ancillary Therapy and Supportive Care Working Group report Biol Blood Marrow Transplant 12 2006 375 396
13. D. Wolff, A. Gerbitz, F. Ayuk Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD Biol Blood Marrow Transplant 16 2010 1611 1628
14. A.H. Filipovich, D. Weisdorf, S. Pavletic National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I Diagnosis and Staging Working Group report Biol Blood Marrow Transplant 11 2005 945 956
15. S.Z. Pavletic, P. Martin, S.J. Lee Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV Response Criteria Working Group report Biol Blood Marrow Transplant 12 2006 252 266
16. D.A. Revicki, D. Osoba, D. Fairclough Recommendations on health-related quality of life research to support labeling and promotional claims in the United States Qual Life Res 9 2000 887 900
17. C. Acquadro, R. Berzon, D. Dubois PRO Harmonization Group Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001 Value Health 6 2003 522 531
18. C.S. Cleeland, T.R. Mendoza, X.S. Wang Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory Cancer 89 2000 1634 1646
19. S. Lee, E.F. Cook, R. Soiffer, J.H. Antin Development and validation of a scale to measure symptoms of chronic graft-versus-host disease Biol Blood Marrow Transplant 8 2002 444 452
20. C. Vitali, S. Bombardieri, R. Jonsson European Study Group on Classification Criteria for Sjgren's Syndrome Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 61 2002 554 558
21. G.H. Guyatt, D. Osoba, A.W. Wu Methods to explain the clinical significance of health status measures Mayo Clin Proc 77 2002 371 383
22. Chronic GVHD Consortium Rationale and design of the Chronic GVHD Cohort Study: improving outcomes assessment in chronic GVHD Biol Blood Marrow Transplant 17 2011 1114 1120
23. R.M. Schiffman, M.D. Christianson, G. Jacobsen Reliability and validity of the Ocular Surface Disease Index Arch Ophthalmol 118 2000 615 621
24. D. Osoba, G. Rodrigues, J. Myles Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 16 1998 139 144
25. ASBMT Chronic GvHD Consensus Project Measurement of therapeutic response in chronic graft-versus-host-disease Response Criteria APPENDICES C & D http://asbmt.affiniscape.com/associations/11741/files/ResponseCriteriaAPPENDIXC- DCalculations.pdf Accessed August 1, 2011
26. G.R. Norman, J.A. Sloan, K.W. Wyrwich Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation Med Care 41 2003 582 592
27. G.R. Norman, J.A. Sloan, K.W. Wyrwich Is it simple or simplistic? Med Care 41 2003 599 600
28. G.M. Fitzmaurice, N.M. Laird, J.H. Ware Applied Longitudinal Analysis 2004 Wiley Hoboken, NJ 325 358
29. J.C. Gardiner, Z. Luo, L.A. Roman Fixed effects, random effects and GEE: what are the differences? Stat Med 28 2009 221 239
30. W.F. Davitt, M. Bloomenstein, M. Christensen, A.E. Martin Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation J Ocul Pharmacol Ther 26 2010 347 353
31. N.J. Friedman Impact of dry eye disease and treatment on quality of life Curr Opin Ophthalmol 21 2010 310 316
32. B.H. Koffler, M. McDonald, D.S. Nelinson LAC-07-01 Study Group Improved signs, symptoms, and quality of life associated with dry eye syndrome: hydroxypropyl cellulose ophthalmic insert patient registry Eye Contact Lens 36 2010 170 176
33. K. Takahide, P.M. Parker, M. Wu Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease Biol Blood Marrow Transplant 13 2007 1016 1021
34. J.H. Lee, P.M. Hyun The reproducibility of the Schirmer test Korean J Ophthalmol 2 1988 5 8
35. K.K. Nichols, G.L. Mitchell, K. Zadnik The repeatability of clinical measurements of dry eye Cornea 23 2004 272 285
36. S.A. Mitchell, D. Jacobsohn, K.E. Thormann Powers A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change Biol Blood Marrow Transplant 17 2011 1619 1629
37. Y. Wang, Y. Ogawa, M. Dogru Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye Bone Marrow Transplant 45 2010 1077 1083